Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.
Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Mantle Cell Lymphoma
- Mantle Cell Mantle Cell Lymphoma (MCL) with Dr. Benjamin Lampson: What Patients Should Know episode
- LLS COVID Antibody Study and COVID resources
- Protecting Patients: COVID and Vaccine Updates episode
- Stem Cell Transplant
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant
- Graft-vs-Host Disease
- Highlights from ASH conference
Additional LLS Support Resources:
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Patti Robinson Kaufmann First Connection Program
- Free booklets
- LLS Public Policy & Advocacy
- Clinical Trial Support Center
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Free Nutrition Consultations
- LLS Advocacy
- Survivorship Workbook
Support for this episode provided by Eli Lilly & Company.